Abbott And Flatiron Health Announce Integration Of Abbott's Comprehensive Precision Oncology Portfolio Into OncoEMR, Flatiron's Cloud-Based EMR Platform

Abbott and Flatiron Health have announced the integration of Abbott's Precision Oncology portfolio into Flatiron's OncoEMR platform, enhancing access to oncology tests across over 1,600 community cancer care centers and 4,700 providers in North America. This integration allows oncologists to order tests and view results directly within their clinical workflow, facilitating more informed treatment decisions and reducing administrative burdens. Key tests included in the integration are Oncotype DX, OncoExTra, Oncodetect, and Riskguard.